Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stabilization of clostridium botulinum neurotoxin complex

a neurotoxin and complex technology, applied in the field of stabilization of clostridium botulinum neurotoxin, can solve the problems of food-borne botulism, short shelf life of the composition, improper storage, etc., and achieve the effects of improving stability properties, and reducing the risk of foodborne botulism

Inactive Publication Date: 2010-09-02
B B SCI
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0016]The present invention seeks to alleviate the problems associated with rapid degradation or denaturation of botulinum neurotoxin by providing a novel composition that exhibits improved stability properties. In particular, the present invention seeks to provide a method for producing a botulinum neurotoxin composition with improved stability properties in an efficient and economically advantageous manner.
[0022]In yet another embodiment, the composition comprises botulinum neurotoxin Type A and gamma-cyclodextrin. In this embodiment, the degradation of the neurotoxin at 4° C. was less than 2%, and the degradation of the neurotoxin at 25° C. was less than 55%, both over a 23-week period. Accordingly, the composition has an increased stability over time.
[0025]In accordance with another aspect of the invention, a method is provided for increasing the stability of botulinum neurotoxin comprising subjecting the botulinum neurotoxin to cyclodextrin to form the complex. Preferably, the molar ratio of the cyclodextrin to botulinum neurotoxin is at least 25:1 to 50:1, and most preferably 39:1. As used herein, the term “cyclodextrin” refers to a compound having a plurality of cyclopyranose units and include alpha, beta, gamma-cyclodextrins, any derivative or salt thereof and any combination thereof. The method of the invention provides a cyclodextrin-botulinum neurotoxin complex having markedly improved stability. Consequently, this improved stability serves to provide a botulinum neurotoxin with increased shelf-life. Preferably, the botulinum neurotoxin is subjected to the cyclodextrin in an aqueous system. The aqueous system has a pH of about 6.8 to 7.6 and can contain between 3 and 25 mM cyclodextrin, between 5 and 25 nM phosphate buffer. Most preferably, the aqueous system comprises 10 mM cyclodextrin, 10 mM sodium phosphate buffer, and has a pH 7.4.

Problems solved by technology

Food-borne botulism results from the consumption of improperly stored foods in which anaerobic C. botulinum grows and releases the toxin.
One major drawback to using the commercially available botulinum toxin preparations is the very short shelf life of the composition.
In this regard, the actual usage of the pharmaceutical composition should be administered within about four hours after reconstitution because the botulinum toxin is very susceptible to denaturation due to surface denaturaion, heat, and alkaline conditions.
In fact, it has been thought that cyclic polymers including cyclodextrins can not be used to preserve or stabilize a botulinum neurotoxin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stabilization of clostridium botulinum neurotoxin complex
  • Stabilization of clostridium botulinum neurotoxin complex
  • Stabilization of clostridium botulinum neurotoxin complex

Examples

Experimental program
Comparison scheme
Effect test

example

Preparation of C. botulinum Type A

[0059]The C. botulinum Type A (strain Hall) complex was prepared by the method described in Cai et al. Enhancement of the Endopeptidase Activity of Botulinum Neurotoxin by Its Associated Proteins and Dithiothreitol, Biochemistry, 1999, 38, 6903-6910, the entire contents of which are incorporated herein by reference. The purified Type A complex was subjected to a buffer exchange using a 5 mL Sephadex G-25 column equilibrated with 10 column volumes of 10 mM sodium phosphate, pH 7.4. The Type A complex was determined to have a typical subunit makeup by SDS-PAGE analysis. The Type A complex, at physiological pH of 7.4, was diluted to a 0.75 mg / mL concentration and 1 mL aliquots were placed into eight 1.5 mL microcentrifuge tubes.

[0060]1.5 mg mL−1 solutions of the Type A Botulinum neurotoxin complex at both 25° C. and 4° C. were analyzed by high performance liquid chromatography using a gel filtration (size exclusion) column (HPLC-GF) both in the presenc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
storage temperaturesaaaaaaaaaa
storage temperaturesaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

A stable composition including a non-covalent complex of a botulinum neurotoxin and a cyclodextrin and a method of preserving botulinum neurotoxin and for producing a botulinum neurotoxin composition with improved stability properties in an efficient and economically advantageous manner. The invention seeks to alleviate the problems associated with rapid degradation or denaturation of botulinum neurotoxin by providing a novel composition that exhibits improved stability properties. The botulinum neurotoxin is preferably stabilized by forming a cyclodextrin complex.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional application of Ser. No. 11 / 525,566 filed Sep. 21, 2006, which claims the benefit of provisional patent application No. 60 / 720,854 filed Sep. 26, 2005, the entire content of each of which is expressly incorporated herein by reference thereto.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention relates to a pharmaceutical composition comprising Clostridium botulinum neurotoxin and to a method of stabilizing the same. Particularly, the present invention is directed to a stabilized pharmaceutical composition including C. botulinum Type A and a cyclodextrin.[0004]2. Description of Related Art[0005]Botulinum neurotoxins are produced from anaerobic bacillus Clostridium botulinum. Seven related protein neurotoxins, known as serotypes A through G, are produced by different strains of the bacillus. Each of the seven serotypes of the botulinum neurotoxins is a large protein having a m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/16C07K14/33A61P21/00
CPCC12Y304/24069C12N9/6416A61P21/00
Inventor SINGH, BAL RAMRESS, ANDREW M.
Owner B B SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com